Administrative Rules are published by the Legislative Reference Service
NOTICE from the Alabama Board of Medical Examiners: Pursuant to Governor Ivey's Executive Order No. 735, an Inventory of Existing Rules that identifies which rules impose regulatory restrictions that are the result of discretionary choices by the agency has been drafted and is being made available for stakeholder input. If you wish to comment on the draft inventory, you may do so by emailing the BME Public Information Officer.
NOTICE from the Medical Licensure Commission: Pursuant to Governor Ivey's Executive Order No. 735, an Inventory of Existing Rules that identifies which rules impose regulatory restrictions that are the result of discretionary choices by the agency has been drafted and is being made available for stakeholder input. If you wish to comment on the draft inventory, you may do so by emailing the MLC Public Information Officer.
540-X-4-.07, Emergency Prescription Refill - proposal is to authorize emergency dispensing of smallest package size if 72-hour supply not available; clarify that Sch. I or II substances are not authorized for emergency dispensing; allow emergency dispensing of Sch. III substances; remove the list of categories of allowable drugs; require that the pharmacist have a record of a prescription within the last 90 days; disallow emergency dispensing of the same drug to the same patient more than one time in a 12-month period; provide that the pharmacist inform the patient that practitioner authorization is required for any future refill; require the statement "Emergency Fill" on the written prescription order; decrease the time to notify the prescriber from 72 to 24 hours.
540-X-12-.02, General Requirements (QACSC-PA) - proposal is to add a provision that a P.A. who applies for a QACSC must provide their Alabama-specific DEA registration number and a copy of their DEA registration certificate; remove references to P.A. dispensing.
540-X-18-.02, General Requirements (QACSC-NP/NM) - proposal is to clarify the authority of the Board to renew, restrict, limit, suspend, or revoke a QACSC; add missing words "any controlled substance"; clarify that the Board may decline to consider an application when the applicant or the collaborating physician is under investigation by the Board.
540-X-26-.01, Definitions; 540-X-26-.04, Collaborative Drug Therapy Management Agreement: Required Terms; 540-X-26-.05, Limitations; 540-X-26-.06, Standards for Physicians; 540-X-26-.07, Standards for Pharmacists - proposals are to clarify when and under what conditions collaborating pharmacists may test and treat for acute, uncomplicated illnesses and injuries.
540-X-2-.03, Definitions Generally Applicable - proposal is to add definitions for Expedited License and Legend Drug pursuant to the Physician Workforce Act of 2023.
540-X-3-.02, Post-Graduate Education Requirements; 540-X-3-.05, Criminal History Background Check; 540-X-3-.07, Additional Requirements for Examination of Certain Applicants - proposed amendments in compliance with the Physician Workforce Act of 2023.
540-X-21, Policy on DATA 2000: Guidelines for the Treatment of Opioid Addiction in the Medical Office - proposal is to repeal the outdated rules.
540-X-1-.19, Public Records Requests - new rule stating the Board's public records requests policy.
540-X-9-.11, Contact with Patients before Prescribing - amended to affirmatively exempt prescribing for the sexual partner(s) of a patient diagnosed with a sexually transmitted disease in accordance with an Expedited Partner Therapy (ET) and/or Patient Delivered Partner Therapy (PDPT) protocol.
540-X-12-.07 and 540-X-18-.07, Utilization of Qualified Alabama Controlled Substances Registration Certificate (QACSC) - amended to remove sections related to guidelines for the use of controlled substances for the treatment of pain.